Merck & Co. (MRK) 10-K2000 FY Annual report

Filed: 13 Mar 01, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	6th grade Avg

New words: active, advisory, alia, allergy, Alpharma, American, Argentina, ASMANEX, Assignment, assume, attained, audited, Australia, average, awaiting, AWP, Barceloneta, barring, Belgium, Boehringer, Canada, cardiovascular, carried, chloride, cited, citing, CLARINEX, cleanup, clinical, Collateral, Colombia, committee, Comprehensive, copy, correct, Deceptive, Defined, Deloitte, Department, depend, desloratadine, discharge, division, Dollar, duration, Economic, economically, EITF, employed, entity, ESI, Eugene, exclusivity, existing, expansion, expense, expropriation, fail, false, family, feasible, fiscal, foresee, formulary, forward, France, frequently, furoate, Germany, GMP, harmful, healthcare, higher, Impax, improperly, Income, inflation, influence, Ingelheim, inspection, intended, inter, interest, introduced, Ireland, Italy, Japan, Judicial, jury, Justice, justified, Komansky, LaRosa, leading, led, Lederle, level, licensed, limitation, LLP, lower, mandated, mature, McGrath, Medicaid, Medicare, metabolite, mometasone, monetary, Mylan, NASONEX, NDA, negatively, noted, obligation, outpatient, PAC, pay, peginterferon, pendency, Pennsylvania, people, petition, plant, Porcine, potassium, preclude, precluded, pressure, PRIME, problem, profitability, promulgated, property, prospective, Public, publicly, Puerto, pulmonary, quantity, quarter, reach, REBETOL, reclassified, reliability, REMICADE, repackaged, Reproductive, resolution, resolve, resolved, respiratory, responding, ribavirin, Rico, Risk, safety, scientifically, scope, Senior, side, Southern, Split, strategy, Subsequently, sued, sufficient, sulfate, supplied, Syndrome, tax, technological, TEMODAR, tenor, thereof, thereunder, thereunto, Touche, treatment, turn, type, undertaken, unknown, update, USPD, vaccine, Vetmedica, vicinity

Removed: Assistant, conducted, Garfield, GENTOCIN, Giralda, Hugh, Madison, ophthalmic, OPTIMMUNE, payable, Schreyer, Silbey, Treasurer, vaginal, Vice, William, Wood, yeast

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

MRK similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23

INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in Registration Statements No. 2-83963, No. 33-19013, No. 33-50606, No. 333-30331 and No.333-87077 on Form S-8, Registration Statement No. 333-853 on Form S-3, Post Effective Amendment No. 1 to Registration Statement No. 2-84723 on Form S-8, Post Effective Amendment No. 1 to Registration Statement No. 2-80012 on Form S-3, Post Effective Amendment No. 1 to Registration Statement No. 2-77740 on Form S-3 and Registration Statements No. 333-12909 and No. 333-30355 on Form S-3 of our reports dated February 16, 2001, appearing in and incorporated by reference in the Annual Report on Form 10-K of Schering-Plough Corporation for the year ended December 31, 2000.

/s/ DELOITTE & TOUCHE, LLP
Parsippany, New Jersey
March 12, 2001